APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Carrier Screening Tests

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Carrier Screening Tests Market Outlook and Growth Opportunities 2026

Report ID 17408676046 March 2026218 pages

Choose your research edition.

Industry ResearchCarrier Screening Tests Industry Research Report 2026144 pages · $2,950 USDIndustry Growth & TrendsGlobal Carrier Screening Tests Industry Growth and Trends Forecast to 2032123 pages · $3,450 USDMarket StructureGlobal Carrier Screening Tests Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Carrier Screening Tests Market Outlook and Growth Opportunities 2026218 pages · $4,250 USDMarket Analysis & ForecastGlobal Carrier Screening Tests Market Analysis and Forecast 2026-2032219 pages · $4,950 USD

Market perspective

The global Carrier Screening Tests market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Carrier Screening Tests is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Carrier Screening Tests is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Carrier Screening Tests is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Carrier Screening Tests market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Carrier Screening Tests market include Thermo Fisher Scientific, Eurofins Scientific, Illumina, Invitae, MedGenome, Myriad Genetics, Roche, Natera and OPKO Health, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Carrier Screening Tests market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Carrier Screening Tests and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Carrier Screening Tests revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Carrier Screening Tests market.

Carrier Screening Tests Segment by Company

Thermo Fisher Scientific

Eurofins Scientific

Illumina

Invitae

MedGenome

Myriad Genetics

Roche

Natera

OPKO Health

23andMe

bioMérieux

EKF Diagnostics

Gene by Gene (myDNA)

Fulgent Genetics

NxGen MDx

Sonic Genetics

My Baby

AncestryDNA

DiaSorin

Grifols

BGI Genomics

Chigene

Jiajian Medical Testing

Genesky

Berry Genomics

Weihansi Biomedical Technology

Annaroad

Carrier Screening Tests Segment by Type

NGS

Whole Exome Sequencing

Others

Carrier Screening Tests Segment by Application

Couple

Individual

Carrier Screening Tests Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Carrier Screening Tests status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Carrier Screening Tests key companies, revenue, market share, and recent developments.

3. To split the Carrier Screening Tests breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Carrier Screening Tests market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Carrier Screening Tests significant trends, drivers, influence factors in global and regions.

6. To analyze Carrier Screening Tests competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Carrier Screening Tests market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Carrier Screening Tests and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Carrier Screening Tests.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Carrier Screening Tests industry.

Chapter 3: Detailed analysis of Carrier Screening Tests company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Carrier Screening Tests in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Carrier Screening Tests in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Carrier Screening Tests Industry Trends Table 2. Carrier Screening Tests Industry Drivers Table 3. Carrier Screening Tests Industry Opportunities and Challenges Table 4. Carrier Screening Tests Industry Restraints Table 5. Global Carrier Screening Tests Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Carrier Screening Tests Revenue Share by Company (2021-2026) Table 7. Global Carrier Screening Tests Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Carrier Screening Tests Key Company Manufacturing Base & Headquarters Table 9. Global Carrier Screening Tests Company, Product Type & Application Table 10. Global Carrier Screening Tests Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Carrier Screening Tests by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of NGS Table 15. Significant Companies of Whole Exome Sequencing Table 16. Significant Companies of Others Table 17. Global Carrier Screening Tests Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 18. Global Carrier Screening Tests Sales Value by Type (2021-2026) & (US$ Million) Table 19. Global Carrier Screening Tests Sales Value by Type (2027-2032) & (US$ Million) Table 20. Global Carrier Screening Tests Sales Value Share by Type (2021-2026) Table 21. Global Carrier Screening Tests Sales Value Share by Type (2027-2032) Table 22. Significant Companies of Couple Table 23. Significant Companies of Individual Table 24. Global Carrier Screening Tests Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Carrier Screening Tests Sales Value by Application (2021-2026) & (US$ Million) Table 26. Global Carrier Screening Tests Sales Value by Application (2027-2032) & (US$ Million) Table 27. Global Carrier Screening Tests Sales Value Share by Application (2021-2026) Table 28. Global Carrier Screening Tests Sales Value Share by Application (2027-2032) Table 29. Global Carrier Screening Tests Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 30. Global Carrier Screening Tests Sales Value by Region (2021-2026) & (US$ Million) Table 31. Global Carrier Screening Tests Sales Value Share by Region (2021-2026) Table 32. Global Carrier Screening Tests Sales Value by Region (2027-2032) & (US$ Million) Table 33. Global Carrier Screening Tests Sales Value Share by Region (2027-2032) Table 34. Global Carrier Screening Tests Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Carrier Screening Tests Sales Value by Country (2021-2026) & (US$ Million) Table 36. Global Carrier Screening Tests Sales Value Market Share by Country (2021-2026) Table 37. Global Carrier Screening Tests Sales Value by Country (2027-2032) & (US$ Million) Table 38. Global Carrier Screening Tests Sales Value Market Share by Country (2027-2032) Table 39. Thermo Fisher Scientific Company Information Table 40. Thermo Fisher Scientific Business Overview Table 41. Thermo Fisher Scientific Carrier Screening Tests Revenue (US$ Million) and Gross Margin (2021-2026) Table 42. Thermo Fisher Scientific Carrier Screening Tests Product Portfolio Table 43. Thermo Fisher Scientific Recent Development Table 44. Eurofins Scientific Company Information Table 45. Eurofins Scientific Business Overview Table 46. Eurofins Scientific Carrier Screening Tests Revenue (US$ Million) and Gross Margin (2021-2026) Table 47. Eurofins Scientific Carrier Screening Tests Product Portfolio Table 48. Eurofins Scientific Recent Development Table 49. Illumina Company Information Table 50. Illumina Business Overview Table 51. Illumina Carrier Screening Tests Revenue (US$ Million) and Gross Margin (2021-2026) Table 52. Illumina Carrier Screening Tests Product Portfolio Table 53. Illumina Recent Development Table 54. Invitae Company Information Table 55. Invitae Business Overview Table 56. Invitae Carrier Screening Tests Revenue (US$ Million) and Gross Margin (2021-2026) Table 57. Invitae Carrier Screening Tests Product Portfolio Table 58. Invitae Recent Development Table 59. MedGenome Company Information Table 60. MedGenome Business Overview Table 61. MedGenome Carrier Screening Tests Revenue (US$ Million) and Gross Margin (2021-2026) Table 62. MedGenome Carrier Screening Tests Product Portfolio Table 63. MedGenome Recent Development Table 64. Myriad Genetics Company Information Table 65. Myriad Genetics Business Overview Table 66. Myriad Genetics Carrier Screening Tests Revenue (US$ Million) and Gross Margin (2021-2026) Table 67. Myriad Genetics Carrier Screening Tests Product Portfolio Table 68. Myriad Genetics Recent Development Table 69. Roche Company Information Table 70. Roche Business Overview Table 71. Roche Carrier Screening Tests Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. Roche Carrier Screening Tests Product Portfolio Table 73. Roche Recent Development Table 74. Natera Company Information Table 75. Natera Business Overview Table 76. Natera Carrier Screening Tests Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. Natera Carrier Screening Tests Product Portfolio Table 78. Natera Recent Development Table 79. OPKO Health Company Information Table 80. OPKO Health Business Overview Table 81. OPKO Health Carrier Screening Tests Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. OPKO Health Carrier Screening Tests Product Portfolio Table 83. OPKO Health Recent Development Table 84. 23andMe Company Information Table 85. 23andMe Business Overview Table 86. 23andMe Carrier Screening Tests Revenue (US$ Million) and Gross Margin (2021-2026) Table 87. 23andMe Carrier Screening Tests Product Portfolio Table 88. 23andMe Recent Development Table 89. bioMérieux Company Information Table 90. bioMérieux Business Overview Table 91. bioMérieux Carrier Screening Tests Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 92. bioMérieux Carrier Screening Tests Product Portfolio Table 93. bioMérieux Recent Development Table 94. EKF Diagnostics Company Information Table 95. EKF Diagnostics Business Overview Table 96. EKF Diagnostics Carrier Screening Tests Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 97. EKF Diagnostics Carrier Screening Tests Product Portfolio Table 98. EKF Diagnostics Recent Development Table 99. Gene by Gene (myDNA) Company Information Table 100. Gene by Gene (myDNA) Business Overview Table 101. Gene by Gene (myDNA) Carrier Screening Tests Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 102. Gene by Gene (myDNA) Carrier Screening Tests Product Portfolio Table 103. Gene by Gene (myDNA) Recent Development Table 104. Fulgent Genetics Company Information Table 105. Fulgent Genetics Business Overview Table 106. Fulgent Genetics Carrier Screening Tests Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 107. Fulgent Genetics Carrier Screening Tests Product Portfolio Table 108. Fulgent Genetics Recent Development Table 109. NxGen MDx Company Information Table 110. NxGen MDx Business Overview Table 111. NxGen MDx Carrier Screening Tests Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 112. NxGen MDx Carrier Screening Tests Product Portfolio Table 113. NxGen MDx Recent Development Table 114. Sonic Genetics Company Information Table 115. Sonic Genetics Business Overview Table 116. Sonic Genetics Carrier Screening Tests Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 117. Sonic Genetics Carrier Screening Tests Product Portfolio Table 118. Sonic Genetics Recent Development Table 119. My Baby Company Information Table 120. My Baby Business Overview Table 121. My Baby Carrier Screening Tests Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 122. My Baby Carrier Screening Tests Product Portfolio Table 123. My Baby Recent Development Table 124. AncestryDNA Company Information Table 125. AncestryDNA Business Overview Table 126. AncestryDNA Carrier Screening Tests Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 127. AncestryDNA Carrier Screening Tests Product Portfolio Table 128. AncestryDNA Recent Development Table 129. DiaSorin Company Information Table 130. DiaSorin Business Overview Table 131. DiaSorin Carrier Screening Tests Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 132. DiaSorin Carrier Screening Tests Product Portfolio Table 133. DiaSorin Recent Development Table 134. Grifols Company Information Table 135. Grifols Business Overview Table 136. Grifols Carrier Screening Tests Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 137. Grifols Carrier Screening Tests Product Portfolio Table 138. Grifols Recent Development Table 139. BGI Genomics Company Information Table 140. BGI Genomics Business Overview Table 141. BGI Genomics Carrier Screening Tests Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 142. BGI Genomics Carrier Screening Tests Product Portfolio Table 143. BGI Genomics Recent Development Table 144. Chigene Company Information Table 145. Chigene Business Overview Table 146. Chigene Carrier Screening Tests Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 147. Chigene Carrier Screening Tests Product Portfolio Table 148. Chigene Recent Development Table 149. Jiajian Medical Testing Company Information Table 150. Jiajian Medical Testing Business Overview Table 151. Jiajian Medical Testing Carrier Screening Tests Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 152. Jiajian Medical Testing Carrier Screening Tests Product Portfolio Table 153. Jiajian Medical Testing Recent Development Table 154. Genesky Company Information Table 155. Genesky Business Overview Table 156. Genesky Carrier Screening Tests Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 157. Genesky Carrier Screening Tests Product Portfolio Table 158. Genesky Recent Development Table 159. Berry Genomics Company Information Table 160. Berry Genomics Business Overview Table 161. Berry Genomics Carrier Screening Tests Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 162. Berry Genomics Carrier Screening Tests Product Portfolio Table 163. Berry Genomics Recent Development Table 164. Weihansi Biomedical Technology Company Information Table 165. Weihansi Biomedical Technology Business Overview Table 166. Weihansi Biomedical Technology Carrier Screening Tests Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 167. Weihansi Biomedical Technology Carrier Screening Tests Product Portfolio Table 168. Weihansi Biomedical Technology Recent Development Table 169. Annaroad Company Information Table 170. Annaroad Business Overview Table 171. Annaroad Carrier Screening Tests Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 172. Annaroad Carrier Screening Tests Product Portfolio Table 173. Annaroad Recent Development Table 174. Research Programs/Design for This Report Table 175. Authors List of This Report Table 176. Secondary Sources Table 177. Primary Sources List of Figures Figure 1. Carrier Screening Tests Product Image Figure 2. Global Carrier Screening Tests Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Carrier Screening Tests Market Size (2021-2032) & (US$ Million) Figure 4. Global Carrier Screening Tests Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. NGS Image Figure 8. Whole Exome Sequencing Image Figure 9. Others Image Figure 10. Global Carrier Screening Tests Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 11. Global Carrier Screening Tests Sales Value Share 2021 VS 2025 VS 2032 Figure 12. Global Carrier Screening Tests Sales Value Share by Type (2021-2032) Figure 13. Couple Image Figure 14. Individual Image Figure 15. Global Carrier Screening Tests Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Carrier Screening Tests Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Carrier Screening Tests Sales Value Share by Application (2021-2032) Figure 18. Global Carrier Screening Tests Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 19. Global Carrier Screening Tests Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 20. North America Carrier Screening Tests Sales Value (2021-2032) & (US$ Million) Figure 21. North America Carrier Screening Tests Sales Value Share by Country (%), 2025 VS 2032 Figure 22. Europe Carrier Screening Tests Sales Value (2021-2032) & (US$ Million) Figure 23. Europe Carrier Screening Tests Sales Value Share by Country (%), 2025 VS 2032 Figure 24. Asia-Pacific Carrier Screening Tests Sales Value (2021-2032) & (US$ Million) Figure 25. Asia-Pacific Carrier Screening Tests Sales Value Share by Country (%), 2025 VS 2032 Figure 26. South America Carrier Screening Tests Sales Value (2021-2032) & (US$ Million) Figure 27. South America Carrier Screening Tests Sales Value Share by Country (%), 2025 VS 2032 Figure 28. Middle East & Africa Carrier Screening Tests Sales Value (2021-2032) & (US$ Million) Figure 29. Middle East & Africa Carrier Screening Tests Sales Value Share by Country (%), 2025 VS 2032 Figure 30. USA Carrier Screening Tests Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 31. USA Carrier Screening Tests Sales Value Share by Type, 2025 VS 2032 & (%) Figure 32. USA Carrier Screening Tests Sales Value Share by Application, 2025 VS 2032 & (%) Figure 33. Canada Carrier Screening Tests Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 34. Canada Carrier Screening Tests Sales Value Share by Type, 2025 VS 2032 & (%) Figure 35. Canada Carrier Screening Tests Sales Value Share by Application, 2025 VS 2032 & (%) Figure 36. Mexico Carrier Screening Tests Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 37. Mexico Carrier Screening Tests Sales Value Share by Type, 2025 VS 2032 & (%) Figure 38. Mexico Carrier Screening Tests Sales Value Share by Application, 2025 VS 2032 & (%) Figure 39. Germany Carrier Screening Tests Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. Germany Carrier Screening Tests Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. Germany Carrier Screening Tests Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. France Carrier Screening Tests Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. France Carrier Screening Tests Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. France Carrier Screening Tests Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. U.K. Carrier Screening Tests Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. U.K. Carrier Screening Tests Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. U.K. Carrier Screening Tests Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Italy Carrier Screening Tests Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Italy Carrier Screening Tests Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Italy Carrier Screening Tests Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Spain Carrier Screening Tests Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Spain Carrier Screening Tests Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Spain Carrier Screening Tests Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. Russia Carrier Screening Tests Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. Russia Carrier Screening Tests Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. Russia Carrier Screening Tests Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Netherlands Carrier Screening Tests Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Netherlands Carrier Screening Tests Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Netherlands Carrier Screening Tests Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Nordic Countries Carrier Screening Tests Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Nordic Countries Carrier Screening Tests Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Nordic Countries Carrier Screening Tests Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. China Carrier Screening Tests Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. China Carrier Screening Tests Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. China Carrier Screening Tests Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Japan Carrier Screening Tests Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Japan Carrier Screening Tests Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Japan Carrier Screening Tests Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. South Korea Carrier Screening Tests Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. South Korea Carrier Screening Tests Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. South Korea Carrier Screening Tests Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. India Carrier Screening Tests Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. India Carrier Screening Tests Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. India Carrier Screening Tests Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. Australia Carrier Screening Tests Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. Australia Carrier Screening Tests Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. Australia Carrier Screening Tests Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Southeast Asia Carrier Screening Tests Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Southeast Asia Carrier Screening Tests Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Southeast Asia Carrier Screening Tests Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. Brazil Carrier Screening Tests Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. Brazil Carrier Screening Tests Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. Brazil Carrier Screening Tests Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Argentina Carrier Screening Tests Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Argentina Carrier Screening Tests Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Argentina Carrier Screening Tests Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Chile Carrier Screening Tests Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Chile Carrier Screening Tests Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Chile Carrier Screening Tests Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Colombia Carrier Screening Tests Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Colombia Carrier Screening Tests Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Colombia Carrier Screening Tests Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Peru Carrier Screening Tests Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Peru Carrier Screening Tests Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Peru Carrier Screening Tests Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Saudi Arabia Carrier Screening Tests Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Saudi Arabia Carrier Screening Tests Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Saudi Arabia Carrier Screening Tests Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Israel Carrier Screening Tests Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Israel Carrier Screening Tests Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Israel Carrier Screening Tests Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. UAE Carrier Screening Tests Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. UAE Carrier Screening Tests Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. UAE Carrier Screening Tests Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Turkey Carrier Screening Tests Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Turkey Carrier Screening Tests Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Turkey Carrier Screening Tests Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Iran Carrier Screening Tests Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Iran Carrier Screening Tests Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Iran Carrier Screening Tests Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Egypt Carrier Screening Tests Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Egypt Carrier Screening Tests Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Egypt Carrier Screening Tests Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Years Considered Figure 115. Research Process Figure 116. Key Executives Interviewed

Scope & coverage.

Types
  • NGS
  • Whole Exome Sequencing
  • Others
Applications
  • Couple
  • Individual
Companies covered
  • Thermo Fisher Scientific
  • Eurofins Scientific
  • Illumina
  • Invitae
  • MedGenome
  • Myriad Genetics
  • Roche
  • Natera
  • OPKO Health
  • 23andMe
  • bioMérieux
  • EKF Diagnostics
  • Gene by Gene (myDNA)
  • Fulgent Genetics
  • NxGen MDx
  • Sonic Genetics
  • My Baby
  • AncestryDNA
  • DiaSorin
  • Grifols
  • BGI Genomics
  • Chigene
  • Jiajian Medical Testing
  • Genesky
  • Berry Genomics
  • Weihansi Biomedical Technology
  • Annaroad

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Carrier Screening Tests Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Carrier Screening Tests Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Carrier Screening Tests Market Dynamics
  1. 2.1 Carrier Screening Tests Industry Trends
  2. 2.2 Carrier Screening Tests Industry Drivers
  3. 2.3 Carrier Screening Tests Industry Opportunities and Challenges
  4. 2.4 Carrier Screening Tests Industry Restraints
3 Carrier Screening Tests Market by Company
  1. 3.1 Global Carrier Screening Tests Company Revenue Ranking in 2025
  2. 3.2 Global Carrier Screening Tests Revenue by Company (2021-2026)
  3. 3.3 Global Carrier Screening Tests Company Ranking (2024-2026)
  4. 3.4 Global Carrier Screening Tests Company Manufacturing Base and Headquarters
  5. 3.5 Global Carrier Screening Tests Company Product Type and Application
  6. 3.6 Global Carrier Screening Tests Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Carrier Screening Tests Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Carrier Screening Tests Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Carrier Screening Tests Market by Type
  1. 4.1 Carrier Screening Tests Type Introduction
  2. 4.1.1 NGS
  3. 4.1.2 Whole Exome Sequencing
  4. 4.1.3 Others
  5. 4.2 Global Carrier Screening Tests Sales Value by Type
  6. 4.2.1 Global Carrier Screening Tests Sales Value by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Carrier Screening Tests Sales Value by Type (2021-2032)
  8. 4.2.3 Global Carrier Screening Tests Sales Value Share by Type (2021-2032)
5 Carrier Screening Tests Market by Application
  1. 5.1 Carrier Screening Tests Application Introduction
  2. 5.1.1 Couple
  3. 5.1.2 Individual
  4. 5.2 Global Carrier Screening Tests Sales Value by Application
  5. 5.2.1 Global Carrier Screening Tests Sales Value by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Carrier Screening Tests Sales Value by Application (2021-2032)
  7. 5.2.3 Global Carrier Screening Tests Sales Value Share by Application (2021-2032)
6 Carrier Screening Tests Regional Value Analysis
  1. 6.1 Global Carrier Screening Tests Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Carrier Screening Tests Sales Value by Region (2021-2032)
  3. 6.2.1 Global Carrier Screening Tests Sales Value by Region: 2021-2026
  4. 6.2.2 Global Carrier Screening Tests Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Carrier Screening Tests Sales Value (2021-2032)
  7. 6.3.2 North America Carrier Screening Tests Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Carrier Screening Tests Sales Value (2021-2032)
  10. 6.4.2 Europe Carrier Screening Tests Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Carrier Screening Tests Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Carrier Screening Tests Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Carrier Screening Tests Sales Value (2021-2032)
  16. 6.6.2 South America Carrier Screening Tests Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Carrier Screening Tests Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Carrier Screening Tests Sales Value Share by Country, 2025 VS 2032
7 Carrier Screening Tests Country-level Value Analysis
  1. 7.1 Global Carrier Screening Tests Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Carrier Screening Tests Sales Value by Country (2021-2032)
  3. 7.2.1 Global Carrier Screening Tests Sales Value by Country (2021-2026)
  4. 7.2.2 Global Carrier Screening Tests Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Carrier Screening Tests Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Carrier Screening Tests Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Carrier Screening Tests Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Carrier Screening Tests Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Carrier Screening Tests Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Carrier Screening Tests Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Carrier Screening Tests Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Carrier Screening Tests Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Carrier Screening Tests Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Carrier Screening Tests Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Carrier Screening Tests Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Carrier Screening Tests Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Carrier Screening Tests Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Carrier Screening Tests Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Carrier Screening Tests Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Carrier Screening Tests Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Carrier Screening Tests Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Carrier Screening Tests Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Carrier Screening Tests Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Carrier Screening Tests Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Carrier Screening Tests Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Carrier Screening Tests Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Carrier Screening Tests Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Carrier Screening Tests Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Carrier Screening Tests Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Carrier Screening Tests Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Carrier Screening Tests Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Carrier Screening Tests Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Carrier Screening Tests Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Carrier Screening Tests Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Carrier Screening Tests Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Carrier Screening Tests Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Carrier Screening Tests Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Carrier Screening Tests Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Carrier Screening Tests Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Carrier Screening Tests Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Carrier Screening Tests Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Carrier Screening Tests Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Carrier Screening Tests Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Carrier Screening Tests Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Carrier Screening Tests Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Carrier Screening Tests Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Carrier Screening Tests Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Carrier Screening Tests Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Carrier Screening Tests Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Carrier Screening Tests Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Carrier Screening Tests Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Carrier Screening Tests Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Carrier Screening Tests Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Carrier Screening Tests Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Carrier Screening Tests Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Carrier Screening Tests Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Carrier Screening Tests Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Carrier Screening Tests Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Carrier Screening Tests Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Carrier Screening Tests Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Carrier Screening Tests Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Carrier Screening Tests Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Carrier Screening Tests Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Carrier Screening Tests Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Carrier Screening Tests Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Carrier Screening Tests Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Carrier Screening Tests Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Carrier Screening Tests Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Carrier Screening Tests Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Carrier Screening Tests Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Carrier Screening Tests Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Carrier Screening Tests Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Carrier Screening Tests Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Carrier Screening Tests Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Carrier Screening Tests Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Carrier Screening Tests Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Carrier Screening Tests Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Carrier Screening Tests Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Carrier Screening Tests Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Carrier Screening Tests Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Carrier Screening Tests Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Carrier Screening Tests Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Carrier Screening Tests Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Carrier Screening Tests Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Carrier Screening Tests Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Carrier Screening Tests Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Carrier Screening Tests Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Carrier Screening Tests Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Thermo Fisher Scientific
  2. 8.1.1 Thermo Fisher Scientific Company Information
  3. 8.1.2 Thermo Fisher Scientific Business Overview
  4. 8.1.3 Thermo Fisher Scientific Carrier Screening Tests Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Thermo Fisher Scientific Carrier Screening Tests Product Portfolio
  6. 8.1.5 Thermo Fisher Scientific Recent Developments
  7. 8.2 Eurofins Scientific
  8. 8.2.1 Eurofins Scientific Company Information
  9. 8.2.2 Eurofins Scientific Business Overview
  10. 8.2.3 Eurofins Scientific Carrier Screening Tests Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Eurofins Scientific Carrier Screening Tests Product Portfolio
  12. 8.2.5 Eurofins Scientific Recent Developments
  13. 8.3 Illumina
  14. 8.3.1 Illumina Company Information
  15. 8.3.2 Illumina Business Overview
  16. 8.3.3 Illumina Carrier Screening Tests Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Illumina Carrier Screening Tests Product Portfolio
  18. 8.3.5 Illumina Recent Developments
  19. 8.4 Invitae
  20. 8.4.1 Invitae Company Information
  21. 8.4.2 Invitae Business Overview
  22. 8.4.3 Invitae Carrier Screening Tests Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Invitae Carrier Screening Tests Product Portfolio
  24. 8.4.5 Invitae Recent Developments
  25. 8.5 MedGenome
  26. 8.5.1 MedGenome Company Information
  27. 8.5.2 MedGenome Business Overview
  28. 8.5.3 MedGenome Carrier Screening Tests Revenue and Gross Margin (2021-2026)
  29. 8.5.4 MedGenome Carrier Screening Tests Product Portfolio
  30. 8.5.5 MedGenome Recent Developments
  31. 8.6 Myriad Genetics
  32. 8.6.1 Myriad Genetics Company Information
  33. 8.6.2 Myriad Genetics Business Overview
  34. 8.6.3 Myriad Genetics Carrier Screening Tests Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Myriad Genetics Carrier Screening Tests Product Portfolio
  36. 8.6.5 Myriad Genetics Recent Developments
  37. 8.7 Roche
  38. 8.7.1 Roche Company Information
  39. 8.7.2 Roche Business Overview
  40. 8.7.3 Roche Carrier Screening Tests Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Roche Carrier Screening Tests Product Portfolio
  42. 8.7.5 Roche Recent Developments
  43. 8.8 Natera
  44. 8.8.1 Natera Company Information
  45. 8.8.2 Natera Business Overview
  46. 8.8.3 Natera Carrier Screening Tests Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Natera Carrier Screening Tests Product Portfolio
  48. 8.8.5 Natera Recent Developments
  49. 8.9 OPKO Health
  50. 8.9.1 OPKO Health Company Information
  51. 8.9.2 OPKO Health Business Overview
  52. 8.9.3 OPKO Health Carrier Screening Tests Revenue and Gross Margin (2021-2026)
  53. 8.9.4 OPKO Health Carrier Screening Tests Product Portfolio
  54. 8.9.5 OPKO Health Recent Developments
  55. 8.10 23andMe
  56. 8.10.1 23andMe Company Information
  57. 8.10.2 23andMe Business Overview
  58. 8.10.3 23andMe Carrier Screening Tests Revenue and Gross Margin (2021-2026)
  59. 8.10.4 23andMe Carrier Screening Tests Product Portfolio
  60. 8.10.5 23andMe Recent Developments
  61. 8.11 bioMérieux
  62. 8.11.1 bioMérieux Company Information
  63. 8.11.2 bioMérieux Business Overview
  64. 8.11.3 bioMérieux Carrier Screening Tests Revenue and Gross Margin (2021-2026)
  65. 8.11.4 bioMérieux Carrier Screening Tests Product Portfolio
  66. 8.11.5 bioMérieux Recent Developments
  67. 8.12 EKF Diagnostics
  68. 8.12.1 EKF Diagnostics Company Information
  69. 8.12.2 EKF Diagnostics Business Overview
  70. 8.12.3 EKF Diagnostics Carrier Screening Tests Revenue and Gross Margin (2021-2026)
  71. 8.12.4 EKF Diagnostics Carrier Screening Tests Product Portfolio
  72. 8.12.5 EKF Diagnostics Recent Developments
  73. 8.13 Gene by Gene (myDNA)
  74. 8.13.1 Gene by Gene (myDNA) Company Information
  75. 8.13.2 Gene by Gene (myDNA) Business Overview
  76. 8.13.3 Gene by Gene (myDNA) Carrier Screening Tests Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Gene by Gene (myDNA) Carrier Screening Tests Product Portfolio
  78. 8.13.5 Gene by Gene (myDNA) Recent Developments
  79. 8.14 Fulgent Genetics
  80. 8.14.1 Fulgent Genetics Company Information
  81. 8.14.2 Fulgent Genetics Business Overview
  82. 8.14.3 Fulgent Genetics Carrier Screening Tests Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Fulgent Genetics Carrier Screening Tests Product Portfolio
  84. 8.14.5 Fulgent Genetics Recent Developments
  85. 8.15 NxGen MDx
  86. 8.15.1 NxGen MDx Company Information
  87. 8.15.2 NxGen MDx Business Overview
  88. 8.15.3 NxGen MDx Carrier Screening Tests Revenue and Gross Margin (2021-2026)
  89. 8.15.4 NxGen MDx Carrier Screening Tests Product Portfolio
  90. 8.15.5 NxGen MDx Recent Developments
  91. 8.16 Sonic Genetics
  92. 8.16.1 Sonic Genetics Company Information
  93. 8.16.2 Sonic Genetics Business Overview
  94. 8.16.3 Sonic Genetics Carrier Screening Tests Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Sonic Genetics Carrier Screening Tests Product Portfolio
  96. 8.16.5 Sonic Genetics Recent Developments
  97. 8.17 My Baby
  98. 8.17.1 My Baby Company Information
  99. 8.17.2 My Baby Business Overview
  100. 8.17.3 My Baby Carrier Screening Tests Revenue and Gross Margin (2021-2026)
  101. 8.17.4 My Baby Carrier Screening Tests Product Portfolio
  102. 8.17.5 My Baby Recent Developments
  103. 8.18 AncestryDNA
  104. 8.18.1 AncestryDNA Company Information
  105. 8.18.2 AncestryDNA Business Overview
  106. 8.18.3 AncestryDNA Carrier Screening Tests Revenue and Gross Margin (2021-2026)
  107. 8.18.4 AncestryDNA Carrier Screening Tests Product Portfolio
  108. 8.18.5 AncestryDNA Recent Developments
  109. 8.19 DiaSorin
  110. 8.19.1 DiaSorin Company Information
  111. 8.19.2 DiaSorin Business Overview
  112. 8.19.3 DiaSorin Carrier Screening Tests Revenue and Gross Margin (2021-2026)
  113. 8.19.4 DiaSorin Carrier Screening Tests Product Portfolio
  114. 8.19.5 DiaSorin Recent Developments
  115. 8.20 Grifols
  116. 8.20.1 Grifols Company Information
  117. 8.20.2 Grifols Business Overview
  118. 8.20.3 Grifols Carrier Screening Tests Revenue and Gross Margin (2021-2026)
  119. 8.20.4 Grifols Carrier Screening Tests Product Portfolio
  120. 8.20.5 Grifols Recent Developments
  121. 8.21 BGI Genomics
  122. 8.21.1 BGI Genomics Company Information
  123. 8.21.2 BGI Genomics Business Overview
  124. 8.21.3 BGI Genomics Carrier Screening Tests Revenue and Gross Margin (2021-2026)
  125. 8.21.4 BGI Genomics Carrier Screening Tests Product Portfolio
  126. 8.21.5 BGI Genomics Recent Developments
  127. 8.22 Chigene
  128. 8.22.1 Chigene Company Information
  129. 8.22.2 Chigene Business Overview
  130. 8.22.3 Chigene Carrier Screening Tests Revenue and Gross Margin (2021-2026)
  131. 8.22.4 Chigene Carrier Screening Tests Product Portfolio
  132. 8.22.5 Chigene Recent Developments
  133. 8.23 Jiajian Medical Testing
  134. 8.23.1 Jiajian Medical Testing Company Information
  135. 8.23.2 Jiajian Medical Testing Business Overview
  136. 8.23.3 Jiajian Medical Testing Carrier Screening Tests Revenue and Gross Margin (2021-2026)
  137. 8.23.4 Jiajian Medical Testing Carrier Screening Tests Product Portfolio
  138. 8.23.5 Jiajian Medical Testing Recent Developments
  139. 8.24 Genesky
  140. 8.24.1 Genesky Company Information
  141. 8.24.2 Genesky Business Overview
  142. 8.24.3 Genesky Carrier Screening Tests Revenue and Gross Margin (2021-2026)
  143. 8.24.4 Genesky Carrier Screening Tests Product Portfolio
  144. 8.24.5 Genesky Recent Developments
  145. 8.25 Berry Genomics
  146. 8.25.1 Berry Genomics Company Information
  147. 8.25.2 Berry Genomics Business Overview
  148. 8.25.3 Berry Genomics Carrier Screening Tests Revenue and Gross Margin (2021-2026)
  149. 8.25.4 Berry Genomics Carrier Screening Tests Product Portfolio
  150. 8.25.5 Berry Genomics Recent Developments
  151. 8.26 Weihansi Biomedical Technology
  152. 8.26.1 Weihansi Biomedical Technology Company Information
  153. 8.26.2 Weihansi Biomedical Technology Business Overview
  154. 8.26.3 Weihansi Biomedical Technology Carrier Screening Tests Revenue and Gross Margin (2021-2026)
  155. 8.26.4 Weihansi Biomedical Technology Carrier Screening Tests Product Portfolio
  156. 8.26.5 Weihansi Biomedical Technology Recent Developments
  157. 8.27 Annaroad
  158. 8.27.1 Annaroad Company Information
  159. 8.27.2 Annaroad Business Overview
  160. 8.27.3 Annaroad Carrier Screening Tests Revenue and Gross Margin (2021-2026)
  161. 8.27.4 Annaroad Carrier Screening Tests Product Portfolio
  162. 8.27.5 Annaroad Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst